Regulus Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
114,005.00
159,743.00
115,319.00
76,111.00
60,074.00
13,935
Total Accounts Receivable
79.00
274.00
10,021.00
1,657.00
373.00
26
Inventories
-
-
-
5,552.00
4,783.00
-
Other Current Assets
3,098.00
4,934.00
8,918.00
4,154.00
1,506.00
1,140
Total Current Assets
117,182.00
164,951.00
134,258.00
87,474.00
66,736.00
15,101
Net Property, Plant & Equipment
3,768.00
3,568.00
5,400.00
11,830.00
9,708.00
7,806
Intangible Assets
1,128.00
1,150.00
1,081.00
1,015.00
775.00
500
Other Assets
987.00
1,811.00
344.00
342.00
590.00
4,520
Total Assets
123,065.00
171,480.00
141,083.00
100,661.00
77,809.00
27,927
ST Debt & Current Portion LT Debt
-
23,397.00
-
-
19,859.00
Accounts Payable
1,172.00
2,188.00
2,717.00
5,840.00
5,743.00
Other Current Liabilities
9,198.00
9,607.00
9,915.00
7,967.00
6,998.00
Total Current Liabilities
10,370.00
35,192.00
12,632.00
13,807.00
32,600.00
Long-Term Debt
11,279.00
-
-
19,802.00
-
Other Liabilities
7,959.00
4,274.00
4,373.00
10,977.00
9,993.00
Total Liabilities
29,608.00
39,466.00
17,005.00
44,586.00
42,593.00
Common Equity (Total)
93,457.00
132,014.00
124,078.00
56,075.00
35,216.00
Total Shareholders' Equity
93,457.00
132,014.00
124,078.00
56,075.00
35,216.00
Total Equity
93,457.00
132,014.00
124,078.00
56,075.00
35,216.00
Liabilities & Shareholders' Equity
123,065.00
171,480.00
141,083.00
100,661.00
77,809.00
About Regulus Therapeutics
View Profile
